7 rezultatus
The present invention relates to a group of secondary amine derivatives that possess anti-obesity and anti-hyperglycaemic properties, to the method of their preparation and to their use as anti-obesity and/or anti-hyperglycaemic agents when formulated into a pharmaceutical composition.
Certain of
FIELD OF THE INVENTION
The present invention belongs to the field of chemical medicine and specifically relates to new stereoisomers of phenylcyclobutylamide derivatives and their pharmaceutically acceptable salts. The present invention also relates to preparation methods of the stereoisomers and
FIELD OF THE INVENTION
The present invention belongs to the field of chemical medicine and specifically relates to new stereoisomers of phenylcyclobutylamide derivatives and their pharmaceutically acceptable salts. The present invention also relates to preparation methods of the stereoisomers and
The present invention relates to a group of secondary amine derivatives that possess anti-obesity and anti-hyperglycaemic properties, to the method of their preparation and to their use as anti-obesity and/or anti-hyperglycaemic agents when formulated into a pharmaceutical composition.
Certain of
The present invention relates to a group of secondary amine derivatives that possess anti-obesity and anti-hyperglycaemic properties, to the method of their preparation and to their use as anti-obesity and/or anti-hyperglycaemic agents when formulated into a pharmaceutical composition.
Certain of
The present invention relates to a group of secondary amine derivatives that possess anti-obesity and anti-hyperglycaemic properties, to the method of their preparation and to their use as anti-obesity and/or anti-hyperglycaemic agents which formulated into a pharmaceutical composition.
Certain of
The present invention relates to a group of secondary amine derivatives that possess anti-obesity and anti-hyperglycaemic properties, to the method of their preparation and to their use as anti-obesity and/or anti-hyperglycaemic agents when formulated into a pharmaceutical composition.
Certain of